EPISODE · Dec 11, 2023 · 39 MIN
Brian I. Rini, MD, FASCO - Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
from PeerVoice Clinical Pharmacology Video · host PeerVoice
Brian I. Rini, MD, FASCO - Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
Embed this episode
What this episode covers
Visit https://www.peervoice.com/EDH860 to view the entire programme with slides. After completing “Brian I. Rini, MD, FASCO - Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma”, participants will be able to: Evaluate available evidence for emerging triplet combination therapies in advanced renal cell carcinoma (RCC); Use patient-, disease-, and treatment-related characteristics to ensure optimal, personalized care of patients with advanced RCC; and Propose evidence-based practical strategies to identify and manage common and serious adverse events associated with combination therapies in patients with RCC.
Ready to play
Brian I. Rini, MD, FASCO - Doubling and Tripling Up: Maximizing Outcomes With Combination Therapies in Renal Cell Carcinoma
No transcript for this episode yet
Similar Episodes
No similar episodes found.